Pauls Dietrich John
SEC insider (Form 3/4/5 filer). CIK 0001760123. President & CEO at DiaMedica Therapeutics Inc. (DMAC). 3 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in MINNEAPOLIS, MN.
Companies Pauls Dietrich John has filed insider reports for
- DiaMedica Therapeutics Inc. (DMAC): Director, Officer, President & CEO
Pauls Dietrich John
CIK: 0001760123
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DMAC
DiaMedica Therapeutics Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Aug 10, 2026DMAC
DiaMedica Therapeutics Inc.
AwardDirect60.2K shares- - Jun 1, 2026DMAC
DiaMedica Therapeutics Inc.
AwardDirectStock Option (right to buy)
380K shares- - Jun 1, 2025DMAC
DiaMedica Therapeutics Inc.
AwardDirectStock Option (right to buy)
600K shares-
1-3 of 3 transactions